
51 - 200 employés
Fondée en 2004
🧬 Biotechnologie
💊 Pharmaceutique
💰 €75 000 000 Post IPO equity en 2024-02
Biotechnology • Pharmaceuticals
Liquidia est une entreprise biopharmaceutique se concentrant sur le développement de thérapies inhalées pour les maladies cardiopulmonaires rares, en particulier l'hypertension artérielle pulmonaire (HTAP) et l'hypertension pulmonaire associée à une maladie pulmonaire interstitielle (HP-MPI). La société s'appuie sur sa technologie propriétaire d'ingénierie de particules PRINT® pour créer des formulations et des méthodes de livraison exclusives visant à améliorer l'efficacité, la tolérance et la commodité des médicaments inhalés ; son portefeuille comprend le trépostinil inhalé (produit commercial) et des candidats en phase clinique comme le L606. Liquidia met l'accent sur le soutien aux patients, le développement clinique et la progression des thérapies pour de meilleurs résultats respiratoires.
🕒 il y a 21 jours
🗣️🇺🇸🇬🇧 Anglais requis
D'où vient cette offre
Publiée sur la page carrières de Liquidia Corporation, pas via un site d'emploi
Repérée par Remote Rocketship il y a 21 jours
Toujours ouverte sur le site de Liquidia Corporation. Vérifiée il y a 3 heures.

51 - 200 employés
Fondée en 2004
🧬 Biotechnologie
💊 Pharmaceutique
💰 €75 000 000 Post IPO equity en 2024-02
Biotechnology • Pharmaceuticals
Liquidia est une entreprise biopharmaceutique se concentrant sur le développement de thérapies inhalées pour les maladies cardiopulmonaires rares, en particulier l'hypertension artérielle pulmonaire (HTAP) et l'hypertension pulmonaire associée à une maladie pulmonaire interstitielle (HP-MPI). La société s'appuie sur sa technologie propriétaire d'ingénierie de particules PRINT® pour créer des formulations et des méthodes de livraison exclusives visant à améliorer l'efficacité, la tolérance et la commodité des médicaments inhalés ; son portefeuille comprend le trépostinil inhalé (produit commercial) et des candidats en phase clinique comme le L606. Liquidia met l'accent sur le soutien aux patients, le développement clinique et la progression des thérapies pour de meilleurs résultats respiratoires.
• Provide strategic framework and guidance for developing, deploying, and continuously improving patient support and affordability programs • Design and maintain programs covering reimbursement support, case management, adherence and persistency, nurse educators, copay assistance, PAP, bridge, and quick-start free drug programs • Develop annual patient support strategies and tactical plans with Market Access and Commercial leadership • Monitor copay accumulators, maximizers, and Alternative Funding Programs and incorporate implications into program design, business rules, and gross-to-net planning • Negotiate and execute patient support program vendor agreements, including scope of work, business rules, service levels, and pricing • Monitor KPIs and SLAs, including time to first fill, benefits investigation accuracy, prior authorization turnaround, adherence, persistency, and case closure rates • Lead quarterly business reviews for patient support program vendors • Manage day-to-day program and vendor operations, escalations, case-level issue resolution, and operational meetings • Develop and maintain SOPs and work instructions across patient support and specialty pharmacy partners • Oversee patient assistance eligibility criteria, income verification, enrollment governance, annual review, and re-certification • Own reporting, scorecards, program utilization, and enrollment funnel performance; translate insights into recommendations • Partner with Commercial Analytics and Finance on copay and free-goods forecasting, accrual support, and gross-to-net implications • Partner with Marketing on patient support program materials • Collaborate with Market Access, Trade and Distribution, Field Reimbursement, Sales, Marketing, Medical Affairs, Quality, Pharmacovigilance, IT, Legal, and Compliance • Ensure adverse event and product complaint intake, documentation, reporting, and vendor training requirements are incorporated into workflows • Address issues affecting patient access, product initiation, or continuity of therapy • Ensure compliance with company policies, HIPAA, OIG guidance, and the federal Anti-Kickback Statute • Participate in company-sponsored meetings, trade shows, and industry conferences • Follow company compliance policies, procedures, and training requirements • Perform other duties as assigned
• Bachelor's degree required • 8+ years of experience in patient services, market access, reimbursement, or distribution within a pharmaceutical or biotechnology manufacturer • 2+ years managing external patient support, HUB, or copay vendor relationships • Demonstrated experience launching a patient services HUB and/or supporting a specialty product launch • Strong familiarity with copay assistance, PAP, bridge and free drug programs, and financial support models required • Experience in access for a pharmacy benefit product required • Experience managing teams and in-line leadership roles • Demonstrated understanding of healthcare compliance frameworks, including HIPAA, OIG guidance, and the federal Anti-Kickback Statute • Ability to travel up to 25% of the time • Direct experience building new patient assistance and patient support programs preferred • Experience in rare disease or orphan product commercialization preferred • Familiarity with pulmonary hypertension, including WHO Group 1 and WHO Group 3 disease states preferred • Understanding of pharmacovigilance integration and compliant patient education practices preferred • Experience with copay accumulator, maximizer, and Alternative Funding Program mitigation strategies preferred • Financial acumen in budgeting, forecasting, and profitability management preferred • Experience leveraging CRM platforms and patient support performance analytics preferred • Experience working in a smaller or growth-stage biopharmaceutical environment preferred
• Competitive compensation package • Medical insurance • Dental insurance • Vision insurance • Short-term disability (STD) • Long-term disability (LTD) • 401(k) Savings Retirement Plan • Employee Stock Purchase Plan (ESPP) • Reasonable accommodation for qualified individuals with disabilities
Postuler MaintenantAméliorez vos chances d'obtenir un entretien en vérifiant votre score de CV avant de postuler.
🕒 il y a 21 jours
Research group leader advancing breakthrough cancer discoveries at BeOne Institute. Setting strategy, leading interdisciplinary teams, and translating innovation into transformative medicines.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 21 jours
Senior Director leading LTSS care management, compliance, and program growth at Centene. Guiding clinical teams and improving outcomes for members needing long-term services and supports.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 21 jours
Senior Director managing strategic accounts and selling enterprise SaaS to biotech and pharma companies. Care Access delivers clinical research and health services to underserved communities.
🇺🇸 États-Unis – Télétravail
💵 $140 000 - $190 000 / an
💰 Grant en 2021-11
⏰ Temps Plein
🟠 Senior
👔 Directeur
🦅 Parrain de Visa H1B
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 21 jours
AVP leading Baylor Genetics' corporate FP&A, budgeting, forecasting, and executive reporting. Governing Adaptive Planning and Tableau-based financial intelligence for healthcare operations.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 22 jours
Senior Director leading analytical development for small-molecule and oligonucleotide medicines at CNS biopharmaceutical Praxis Precision Medicines. Setting CMC strategy, building teams, and guiding regulatory readiness.
🇺🇸 États-Unis – Télétravail
💵 $250 000 - $275 000 / an
⏰ Temps Plein
🟠 Senior
👔 Directeur
🦅 Parrain de Visa H1B
🗣️🇺🇸🇬🇧 Anglais requis